Breathing News and Research

RSS

Using mindfulness approach to tackle opioid crisis

Boston Medical Center was awarded a multi-million dollar grant from the National Institutes of Health to improve function for chronic lower back pain (cLBP) using a non-pharmacologic approach.

11 Oct 2019

Combination drug appears to improve lung health in patients with cystic fibrosis, but with caveats

In adolescent and adult patients with cystic fibrosis taking lumacaftor-ivacaftor (ORKAMBI), the combination drug appears to improve lung function and body weight and reduce the need for intravenous antibiotic treatment, according to a French study published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

11 Oct 2019

Researchers identify genetic mutation that causes idiopathic pulmonary fibrosis

Researchers in Japan have identified a genetic mutation that causes a severe lung disease called idiopathic pulmonary fibrosis by killing the cells lining the lung's airways.

10 Oct 2019

UD engineering professor receives NIH grant to accelerate study of lung fibrosis

University of Delaware Professor April Kloxin has been awarded a National Institutes of Health Director's New Innovator Award from the NIH Common Fund's High-Risk, High-Reward Research program, which supports highly innovative research proposals.

9 Oct 2019

Countries propose ban on e-cigarettes amid concerns about harmful health effects

A string of deaths in the United States linked to the use of electronic cigarettes has stirred concern worldwide about their growing popularity among young people and the health risks they pose to millions of users.

9 Oct 2019

New research explores the impact of police stops on youth’s mental health

New research looks into the impact police stops have on the mental health of youth.

9 Oct 2019

New discovery brings scientists closer to developing an RSV vaccine

Scientists have made an important discovery that could lead to a vaccine that will protect against respiratory syncytial virus (RSV).

9 Oct 2019

New drug Aliskiren shows promise for heart failure patients

A study published in the International Journal of Molecular Sciences, as part of a special issue “Heart Failure: From Molecular Basis to Therapy”, in August 2019, shows that aliskiren, a drug approved by the US Food and Drug Administration (FDA), can improve survival for over 5 years, on average, and enhance life quality in patients who have been correctly diagnosed with heart failure.

9 Oct 2019

CDC advises vaccination for pregnant women against flu and whooping cough

The Centre for Disease Prevention and Control (CDC) has recommended that all pregnant women should be vaccinated against influenza and whooping cough to provide protection to the baby against these deadly infections during the first few months of their lives. The CDC recommendation released this week Tuesday (8th of October 2019), is that these vaccines against flu and whooping cough are safe for pregnant women and do not affect their unborn babies adversely.

9 Oct 2019

Study receives NCI grant to explore better treatment for brain tumors in children

Children with recurrent brain tumors or newly diagnosed, particularly aggressive tumors called diffuse intrinsic pontine gliomas are being enrolled in the first study to examine the efficacy of a drug that inhibits an enzyme these tumors use to protect themselves from the child's natural immune response.

8 Oct 2019

Ground-breaking online tool launched to help people maintain good mental health

A groundbreaking online tool has been launched to help people gain better control over their mental health.

8 Oct 2019

Important tips for parents to help manage their child's asthma in the fall

Allergies and other environmental factors can make asthma harder to manage when the season changes to fall.

7 Oct 2019

People greatly impact the air chemistry of office rooms where they work

Just by breathing or wearing deodorant, you have more influence over your office space than you might think, a growing body of evidence shows.

4 Oct 2019

GW researchers to study the underlying pathophysiology of myasthenia gravis

The National Institutes of Health awarded a research team at the George Washington University $7.8 million to establish a rare disease network for myasthenia gravis. The network, which will be part of 25 established NIH Rare Diseases Clinical Research Networks, will include basic and clinical investigators, patient advocacy groups, and biotechnology and pharmaceutical companies working together to enhance therapeutic development for this rare disease.

4 Oct 2019

Major global health initiative could save hundreds of thousands of babies in Africa

Hundreds of thousands of babies could be saved through a major global health initiative launched here today to improve newborn hospital care throughout sub-Saharan Africa.

4 Oct 2019

KIT researchers develop close-to-reality computer models of the heart

Digital simulations of human organs can be used to study the development of diseases and to customize therapies for patients.

4 Oct 2019

Firefighters call for governmental action to protect them from cancer

Firefighters in the UK are calling on the government for more health protection, after researchers find they are at an increased risk of cancer.

2 Oct 2019

Many Italian truck drivers suffer from sleep-related breathing problem, shows survey

A survey of 905 Italian truck drivers has shown that approximately half suffer from at least one sleep-related breathing problem that potentially can cause drivers to fall asleep at the wheel.

30 Sep 2019

Smart shirt technology is a promising tool for monitoring lung disease

A smart shirt that measures lung function by sensing movements in the chest and abdomen has proved to be accurate when compared to traditional testing equipment, according to research presented at the European Respiratory Society International Congress.

30 Sep 2019

Experimental treatment shows early promise to help nearly half of DMD patients

A new therapeutic being tested by University of Alberta researchers is showing early promise as a more effective treatment that could help nearly half of patients with Duchenne muscular dystrophy.

25 Sep 2019